HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tetanus toxin binding to neuroblastoma cells differentiated by antimitotic agents.

Abstract
We have examined the binding of tetanus toxin (TT) to surface receptors of neuroblastoma cells by flow cytometry following chemically induced differentiation. Cells were treated with mitomycin C, bromodeoxyuridine, prostaglandin E1 or cyclic adenosine monophosphate at different doses, alone or in combination for 4 days. Cells extended long neurites within 24 h in the presence of prostaglandin/cyclic AMP or mitomycin/bromodeoxyuridine treatment while single-drug treatment was less efficient in morphological differentiation of these cells. Cells exposed to the drug combinations stopped growing after 3 days while flow-cytometric analysis of DNA levels of each cell stained with propidium iodide indicated that at least 60% of these cells were arrested in phase G0/G1 of the cell cycle. Drug-treated cultures were stained for TT binding by immunofluorescence of cells in suspension and analyzed by flow cytometry. Chemically differentiated N2AB-1 cells were shown to bind significantly more TT than control cultures. Receptors for TT could be saturated by increasing doses of TT and differentiated cells bound twice as much toxin at saturation as did control cells. Immunofluorescence of TT binding to monolayers revealed staining in a stippled fashion along all neurites and cell bodies. These data support the concept that drugs which stimulate differentiation of neuroblastoma cells as determined by morphological and cell-cycle criteria also increase the presence of ganglioside receptors on the cell surface available for toxin binding.
AuthorsM F Notter, J F Leary
JournalBrain research (Brain Res) Vol. 391 Issue 1 Pg. 59-68 (Apr 1986) ISSN: 0006-8993 [Print] Netherlands
PMID3006877 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Mitomycins
  • Receptors, Cell Surface
  • Receptors, Immunologic
  • Tetanus Toxin
  • ganglioside receptor
  • Mitomycin
  • Cyclic AMP
  • Alprostadil
  • Bromodeoxyuridine
Topics
  • Alprostadil (pharmacology)
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Bromodeoxyuridine (pharmacology)
  • Cell Differentiation (drug effects)
  • Clone Cells
  • Cyclic AMP (pharmacology)
  • Mice
  • Mitomycin
  • Mitomycins (pharmacology)
  • Neuroblastoma
  • Neurons (metabolism)
  • Receptors, Cell Surface
  • Receptors, Immunologic (metabolism)
  • Tetanus Toxin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: